Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To analyse the control rate of irbesartan/hydrochlorothiazide(HCTZ) (COAPROVEL) in the
treatment of patients with mild to moderate primary hypertension.